Search

everythinglearnresearchcommunity

for

Search:↓

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Diane 35 plus finasteride is more effective for treating hirsutism.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.